EIS Cash Payout in Singapore

What expenditure can be converted into cash?

Cash conversion is available for qualifying expenditure relating to:

• R&D undertaken in Singapore;
• registration of intellectual property;
• acquisition and licensing of qualifying intellectual property rights;
• qualifying employee training; and
• qualifying innovation projects carried out with approved partners.

The separate EIS incentive for AI adoption for YA 2027 and YA 2028 is not eligible for cash conversion.

Explore the full Enterprise Innovation Scheme ->

Partial cash conversion

For qualifying R&D expenditure, businesses do not need to convert the entire amount into cash.

Partial cash conversion is permitted for:

• qualifying R&D undertaken in Singapore;
• licensing of intellectual property rights;
• qualifying training; and
• qualifying innovation projects with approved partners.

This creates an important planning opportunity for R&D-intensive businesses: part of the qualifying expenditure can be converted into immediate cash while the remaining qualifying expenditure can continue to support the relevant enhanced tax deduction.

Different rules apply to IP registration and acquisition of IPRs, where partial conversion is generally not available on the same basis.

Government grants and subsidies

Where qualifying expenditure is supported by a Government grant or subsidy, EIS benefits are generally calculated on the expenditure net of that support.

The same principle applies when determining expenditure available for cash conversion.

For GST-registered businesses, recoverable input GST should also not form part of the qualifying expenditure.

Understand qualifying R&D expenditure ->

Why loss-making R&D companies should think ahead

Early-stage technology and R&D-intensive companies commonly invest heavily before reaching profitability.

During that period, an enhanced R&D tax deduction may produce little or no immediate cash-tax saving because there is insufficient taxable income against which to use it.

That does not necessarily mean the R&D tax claim has no value.

Subject to the applicable tax conditions, unused deductions can contribute to unutilised tax losses that may be available to offset taxable income in future Years of Assessment. Depending on the circumstances, current-year unutilised losses may also interact with Singapore's carry-back or group-relief rules.

For an early-stage company, claiming qualifying R&D can therefore build a future tax shield even when the business is not yet paying corporate income tax.

Profitability can arrive before cash does

The point at which this becomes important is often the transition from growth-stage losses to profitability.

A company can become profitable for accounting and tax purposes while still being cash-constrained.

Revenue may have been earned and recognised, but customer receivables may not yet have been collected. At the same time, the company may still be investing heavily in employees, product development and commercial expansion.

The result can be an uncomfortable mismatch:

A company that has built an appropriate pool of tax losses during its earlier R&D-intensive years may be in a materially stronger position when this transition occurs.

Those losses can potentially reduce future taxable income, subject to the applicable utilisation conditions, and therefore reduce the cash tax burden at a point where working capital remains valuable.

Why waiting until profitability can be the wrong approach

A loss-making business may be tempted to ignore R&D tax completely on the basis that it is not currently paying tax.

That can be short-sighted.

A robust R&D tax position is built from:

• identifying the qualifying projects;
• assessing eligibility;
• establishing the correct claimant;
• identifying qualifying costs;
• maintaining technical evidence; and
• preparing the appropriate claim documentation.

Doing this while the projects are active creates a stronger and more consistent evidence trail than treating R&D tax only as an issue to investigate after profitability has arrived.

The strategic question is therefore not simply:

"Do we save tax this year?"

It is:

"What tax position should we build now for the business we expect to become?"

How the EIS cash payout can help bridge the early-stage period

The cash payout can make this strategy more practical for companies where cash is constrained today but preserving future tax deductions still matters.

Because partial conversion of qualifying R&D expenditure is permitted, an eligible company can choose to convert part of its expenditure into immediate cash while retaining tax deductions on the remainder.

For example, assume an eligible company incurs S$300,000 of qualifying R&D expenditure in Singapore while it is still loss-making.

One possible approach would be:

• convert S$100,000 of qualifying expenditure into cash;
• receive S$20,000 under the EIS cash payout; and
• retain the applicable R&D tax deductions on the remaining S$200,000 of qualifying expenditure.

The converted S$100,000 would no longer generate the corresponding tax deduction. The balance remains subject to the normal R&D and EIS rules.

This can create a useful balance between cash today and tax value for the future.

The cash payout is not restricted to a particular subsequent use. For an R&D-intensive business, it can therefore help finance the work needed to identify, prepare and substantiate the R&D tax claim, including specialist advisory support. Because only the expenditure actually converted loses the corresponding tax deduction, the business can use part of the qualifying expenditure to generate cash now while preserving the R&D tax position on the remaining qualifying expenditure. Depending on the size of the payout and the cost of support, this can substantially offset - and in some cases potentially cover - the immediate cost of managing the claim.

This does not mean cash conversion is always optimal. A company with taxable income, usable group relief or another efficient route to utilise the enhanced deduction may obtain significantly greater value by retaining the tax deduction.

The decision should be modelled before the cash election is made because the election is irrevocable.

Can you claim both the cash payout and the tax deduction?

Not on the same expenditure.

Once qualifying expenditure has been converted into cash, that amount is no longer available for the corresponding tax deduction or allowance.

The cash-conversion election is also irrevocable.

This is why the allocation between cash conversion and enhanced deductions should be decided before the application is submitted.

For qualifying R&D expenditure, partial conversion provides flexibility: one portion can be converted to cash while the remaining qualifying expenditure continues through the R&D tax claim.

How Reeve | R&D supports an R&D-related EIS cash payout

The cash-payout election should be treated as one decision within the wider R&D tax claim, not as a standalone administrative form.

For an R&D-related EIS position, this can include:

1. identifying and scoping potential R&D projects;
2. assessing technical eligibility;
3. establishing the appropriate claimant;
4. identifying and quantifying qualifying expenditure;
5. calculating the enhanced R&D tax position;
6. modelling cash conversion against retaining the tax deduction;
7. determining the appropriate amount of R&D expenditure to convert, where applicable;
8. preparing the R&D Claim Form and supporting technical and financial documentation;
9. supporting the EIS cash-payout application; and
10. supporting subsequent clarification or substantiation if the position is reviewed.

For an early-stage R&D company, this approach can allow the tax position to be built consistently while the business is still investing and loss-making, rather than starting the process only after corporate tax becomes payable.

The objective is to balance cash needs today with the tax position the business may need tomorrow.

Assess your EIS cash payout options

We can assess your qualifying R&D expenditure, current and expected tax position and cash-conversion eligibility before determining whether the EIS cash payout or enhanced R&D deduction is the more appropriate approach.